Annexon (ANNX) traded down -1.33 % during a 24 hours period ending at 09:41 AM Central Europe on Tuesday 27th. One Annexon stock can currently be bought for about USD 3.7 on popular exchanges. Current supply of Annexon stocks is 188.8 mn. Annexon has a current market capitalization of USD 716.6 mn and approximately USD 9.8 mn worth of Annexon was traded on exchanges in the last 24 hours. Since last month end, Annexon has traded -7.73 % down. Simple moving average of last 200 days is at USD 5.26. The highest price of past 52 weeks was recorded at USD 7.18 on 01/23/2026. 52 weeks low was at USD 2.54 on 11/13/2025.

Here is how related stocks have performed in the past 24 hours:

  • Standard Motor Prods (SMP) traded up 0.03 % and now trades at USD 37.28. Standard Motor Prods has a market capitalisation of USD 837.5 mn. Current price/earnings ratio for Standard Motor Prods is 9.46.

  • Suncoke Energy (SXC) traded down -2 % and now trades at USD 9.81. Suncoke Energy has a market capitalisation of USD 847.1 mn.

  • Crossamerica (CAPL) traded up 0.45 % and now trades at USD 22.2. Current market capitalisation for Crossamerica is USD 851.3 mn. Current price/earnings ratio for Crossamerica is 16.25.

  • Obsidian Therapeutics (OBX) traded down -0.86 % and now trades at USD 13.86. Current market capitalisation for Obsidian Therapeutics is USD 846.3 mn.

  • Arbutus Biopharma (ABUS) traded flat 0 % and now trades at USD 4.2. Current market capitalisation for Arbutus Biopharma is USD 834.9 mn. Arbutus Biopharma has a current price to earnings ratio of 5.3.

About Annexon

Annexon Inc., operating under the name Annexon Biosciences, is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company specializes in developing novel therapies for auto-immune and neurodegenerative diseases affecting body, eyes, and brain. Annexon Biosciences provides health care services for patients residing in the state of California. You can find more information about the company and its activities on their website, www.annexonbio.com , and they are listed on the Nasdaq stock exchange.